ACEI |
= Angiotensin-converting
enzyme inhibitor |
|
IL |
=
Interleukin |
AKI |
= Acute kidney injury |
|
KDIGO |
= Kidney
Disease Improving Global Outcomes |
AKIN |
= Acute Kidney Injury
Network |
|
KIM-1 |
= Kidney
injury molecule 1 |
ARB |
= Angiotensin II receptor
antagonist |
|
L-FABP |
= Liver-type
fatty acid binding protein |
AUC |
= Area under curve |
|
NAC |
=
N-acetylcysteine |
BP |
= Blood pressure |
|
NGAL |
= Neutrophil
gelatinase-associated lipocalin |
CABG |
= Coronary artery bypass
grafting |
|
RAS |
=
Renin-angiotensin system |
CPB |
= Cardiopulmonary
bypass |
|
RIFLE |
=
Risk, Injury, Failure, Loss of kidney function, and End-stage kidney
disease |
eGFR |
= Estimated glomerular
filtration rate |
|
GDF-15 |
= Growth-differentiation
factor-15 |
|
SAS |
=
Sympathetic-adrenomedullary system |
GFR |
= Glomerular filtration
rate |
|
SCr |
= Serum
creatinine |
h-FABP |
= Heart-type fatty acid
binding protein |
|
TIMP-2 |
= Tissue
inhibitor of metalloproteinases-2 |
IGFBP7 |
= Insulin-like growth
factor binding protein 7 |
|
USA |
= United
States of America |